SCHEMBL6833903

SCHEMBL6833903

Cc1sc(C(=O)Nc2ccc(Br)cc2C(=O)O)cc1S(=O)(=O)NC1Cc2ccccc2C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
PPARG P37231 1/20 0.42
PPARD Q03181 1/20 0.42
PPARA Q07869 1/20 0.42
PRSS12 P56730 1/20 0.41
AKR1C2 P52895 3/20 0.41
AKR1C1 Q04828 3/20 0.41
AKR1C4 P17516 1/20 0.41
AKR1C3 P42330 1/20 0.41
METAP2 P50579 2/20 0.40
MAPT P10636 3/20 0.39
RPA1 P27694 1/20 0.39
GFER P55789 1/20 0.39
ALB P02768 1/20 0.38
NR1H2 P55055 1/20 0.37
BCL2L1 Q07817 1/20 0.37
MCL1 Q07820 1/20 0.37
CCR8 P51685 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6814190 0.83 MCHR1 (0.47) MEN1KMT2AMAPTCCR8
SCHEMBL6834099 0.83 PRSS12 (0.42) MEN1KMT2APPARGPPARDPPARA
SCHEMBL6357975 0.83 MEN1 (0.64) MEN1KMT2APPARGPPARDPPARA
SCHEMBL6355358 0.80 MEN1 (0.53) MEN1KMT2APPARGPPARDPPARA
SCHEMBL6353643 0.80 LMNA (0.49) MEN1KMT2APPARGPPARDPPARA
SCHEMBL6351288 0.79 PPARG (0.52) MEN1KMT2APPARGPPARDPPARA
SCHEMBL6352363 0.79 MAPT (0.52) MEN1KMT2APPARGPPARDPPARA
SCHEMBL6833361 0.79 PPARG (0.49) MEN1KMT2APPARGPPARDPPARA
SCHEMBL6350870 0.77 PPARG (0.61) MEN1KMT2APPARGPPARDPPARA
SCHEMBL6351026 0.77 LMNA (0.51) MEN1KMT2APPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 MEN1 4132/4885KMT2A 2853/4885PPARG 285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.